BNB$724.29+0.11%BRENT$108.57+3.78%BTC$77,787+0.16%COPPER$6.37-1.51%DJI$52,573+0.98%DOGE$0.0843-0.08%DXY99.58+0.46%ETH$2,522+0.11%GOLD$4,312-0.88%NDX$29,368+0.91%SILVER$63.27-1.55%SOL$101.53-0.04%SPX$7,657+0.86%US10Y4.97+0.63%VIX17.68+11.62%BNB$724.29+0.11%BRENT$108.57+3.78%BTC$77,787+0.16%COPPER$6.37-1.51%DJI$52,573+0.98%DOGE$0.0843-0.08%DXY99.58+0.46%ETH$2,522+0.11%GOLD$4,312-0.88%NDX$29,368+0.91%SILVER$63.27-1.55%SOL$101.53-0.04%SPX$7,657+0.86%US10Y4.97+0.63%VIX17.68+11.62%
MoneyMarket365.comReal-time markets + AI-ranked and AI-analyzed financial news
·Confidence 85%

AstraZeneca's Breast Cancer Drug Trial Failure Could Impact Sales

Key takeaways

  • AstraZeneca's recent breast cancer pill trial failure may lead to a loss of several billion dollars in potential sales, analysts warn.
#AstraZeneca#Pharmaceuticals#Breast Cancer

Analysis

AstraZeneca's recent breast cancer pill trial failure may lead to a loss of several billion dollars in potential sales, analysts warn.

0 likes · 0 dislikes

Comments & Replies

with Google or GitHub to join the discussion.

  • No comments yet be the first to share your view.